Motor vehicles; motors, engines, parts, fittings and accessories for motor vehicles in this class but excluding tyres and tubes for vehicles

Minivans, sports cars, buses, passenger cars, motor cycles, steering wheels for automobiles, wheels for automobiles

Drug delivery agents in the form of capsules, powders, tablets, intra-nasal spray, intra-nasal mist, dissolvable films, and pastilles that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of transdermal patches that facilitate the delivery of pharmaceutical preparations.

Custom manufacture of pharmaceuticals; material transformation services, namely, freeze drying compounds in the nature of active pharmaceutical ingredients and biologicals for pharmaceuticals and nonfood articles; material transformation services, namely, freeze drying food products and nonfood articles.

Pharmaceuticals; Pharmaceutical compositions; Pharmaceutical products; Pharmaceutical drugs; Pharmaceutical preparations; Pharmaceutical preparations for human use; Pharmaceutical preparations for nasal use; Pharmaceutical preparations for oral use; Pharmaceutical preparations for skin care; Ophthalmic pharmaceutical preparations; Pharmaceutical preparations for personal use; Pharmaceutical preparations for use as laxative; Pharmaceutical creams; Pharmaceutical tablets; Topical pharmaceutical compositions; Transdermal patches for administering pharmaceuticals; Syrups for pharmaceutical purposes; Chemical preparations for pharmaceutical purposes; Injectable solutions for medical purposes

Wholesale services for pharmaceutical, veterinary and sanitary preparations and medical supplies; Retail services for pharmaceutical, veterinary and sanitary preparations and medical supplies

Nicotine gum for use as an aid to stop smoking

Pharmaceutical drugs

Pharmaceutical preparations; Nutritional supplements

Business management

Capsules for medicines; Dragees (medicines); Extracts of medicinal herbs; Extracts of medicinal plants; Fruit flavoured tea for medicinal use; Chemical preparations for medicinal purposes; Chemical reagents for use in medicine; Dietetic foods for medicinal purposes; Dietetic substances for medicinal purposes; Beverages adapted for medicinal purposes; Aromatic teas (for medicinal use); Deer velvet medicinal substance; Fruit tea medicinal purposes; Herb preparations for medicinal purposes; Herbal beverages for medicinal use; Herbal compounds for medicinal use; Herbal extracts for medicinal purposes; Herbal infusions for medicinal use; Herbal medicine; Herbal preparations (preserved) for medicinal use; Herbal preparations containing peppermint oil (for medicinal use); Herbal preparations for medicinal purposes; Herbal preparations for medicinal use; Herbal preparations for use in medicine; Herbal tea for medicinal use; Herbal teas for medicinal purposes; Herbs for medicinal purposes; Herbs for smoking (for medicinal purposes); Homeopathic medicines; Horns and antlers and horn and antler products (medicinal substances); Implantable medicines; Infusions for medicinal purposes; Infusions for medicinal purposes made from herbs; Jasmine tea for medicinal purposes; Magnesium hydroxide for medicinal use; Medical infusions (medicinal); Medicinal alcohol; Medicinal beverages; Medicinal creams for the protection of the skin; Medicinal drinks; Medicinal embrocations; Medicinal food supplements; Medicinal food supplements for animals; Medicinal hair growth preparations; Medicinal herbal infusions; Medicinal herbal preparations; Medicinal herbs; Medicinal infusions; Medicinal mud; Medicinal oils; Medicinal ointments; Medicinal preparations; Medicinal roots; Medicinal salts; Medicinal sediment (mud); Medicinal substances; Medicinal tea; Medicine; Medicine boxes sold filled; Medicine cases (portable) (filled); Medicine for circulatory diseases; Medicine tonics; Medicines for alleviating constipation; Medicines for animals; Medicines for counteracting ailments; Medicines for dental purposes; Medicines for human purposes; Medicines for human use; Medicines for preventing ailments; Medicines for treatment of the heart; Medicines for use in the treatment of indigestion; Medicines for veterinary purposes; Medicines in tablet form; Microorganisms in culture form for use in medicine; Mineral waters for medicinal purposes; Natural oils (medicinal); Oils for use in medicine; Orange flavoured tea for medicinal purposes; Pennyroyal (medicinal oil); Peppermint pastilles (confectionery), for medicinal use; Peppermint sweets for medicinal use; Peppermints for medicinal use; Plant compounds for use as dietary supplements (medicinal); Pocket medicine cases (fitted); Preparations for medicinal purposes derived from flowers; Preparations for medicinal purposes derived from herbs; Preparations of herbs for medicinal use; Products containing antibodies for use in medicine; Seawater for medicinal bathing; Sera (medicinal); Serotherapeutic medicines; Serum (medicinal); Sulfonamides (medicines); Tablets for medicines; Tea for medicinal purposes; Tea substitutes (for medicinal use); Tonics (medicinal) based on plant extracts; Tonics (medicine)

Discount store services (retail, wholesale, or sales promotion services); Wholesale services; Wholesale services for pharmaceutical, veterinary and sanitary preparations and medical supplies

Studies for combined compound functional mechanism on animals; cancer research for medical purposes; early evaluation for implementation of the new drugs; pharmaceutical research; scientific surveys for medical purposes; chemical analysis services; research and analysis of biochemistry; chemical research service; chemical analysis assessment service; chemical research and analysis; chemical synthesis assessment service; chemical analysis; chemistry services; chemical research; cosmetic research; structural and functional analysis of genomes; stem cell research services; biotechnological research; blood analysis service; genetic screening for scientific purposes; biological cloning services; research and development of antibodies; genetic testing for scientific research; bacteriological research and analysis; biomedical research; medical research; drug development; medical laboratory service; development of pharmaceutical preparations and pharmaceuticals; medical research service; biological research and analysis; bacteriological research; biological research; clinical trials; computer programming of medical aspects; drug evaluation; pharmaceutical research.

Medicinal compounds containing cannabis, cannabis derivatives, natural cannabinoids, or synthetic cannabinoids; medicinal compounds containing cannabis, cannabis derivatives, natural cannabinoids, or synthetic cannabinoids for treating headaches, neurodegeneration, neurogenesis, epilepsy, childhood epilepsy, paediatric encephalopathies, pain, cancer, managing the effects of chemotherapy, Tourette Syndrome, post-traumatic stress disorder (PTSD), nausea, vomiting, premenstrual syndrome (PMS), neurologic conditions, sleep disorders, cognitive decline, facial pain, spasms, gastrointestinal diseases, rare diseases, Alzheimer's disease, appetite loss, cancer, Crohn's disease, anorexia, bulimia, epilepsy, glaucoma, schizophrenia, multiple sclerosis, muscle spasms, nausea, pain, headaches, wasting syndrome (cachexia), and diseases classified as "orphan" by the US Food and Drug Administration, namely, medicinal compounds containing cannabis, cannabis derivatives, natural cannabinoids, or synthetic cannabinoids for treating diseases and medical conditions classified as "orphan" by the US food and drug administration, namely, Lennox-Gastaut Syndrome, Dravet Syndrome, CDKL5, 15q Duplication Syndrome, KCNQ2 related epileptic encephalopathy, SCN8A related epileptic encephalopathy, Electrical status epilepticus in sleep (ESES), Landau-Kleffner syndrome, Continuous spikes and waves during sleep, Tuberous sclerosis complex, Doose Syndrome, Otahara Syndrome, Rett Syndrome, West Syndrome, SYNGAP related epileptic encephalopathy, Fragile X Syndrome, epilepsy with focal cortical dysplasia type II, KCNT1 related epileptic encephalopathy, SCN2A related epileptic encephalopathy, STXBP1 related epileptic encephalopathy, KAND KIF1A related epileptic encephalopathy, HNRNPH2 related epileptic encephalopathy, Phelan-McDermid Syndrome - SHANK3, Angelman Syndrome, Established Status Epilepticus, Refractory Status Epilepticus, Juvenile Myoclonic Epilepsy/Janz Syndrome, Catamenial epilepsy, Drug resistant mesial temporal lobe epilepsy, Occipital Lobe epilepsy, Jeavons syndrome, Benign Rolandic epilepsy or be; nign childhood epilepsy with centrotemporal spikes (BCECTS), Epilepsy with myoclonic absences, Childhood absence epilepsy (CAE), Tuberous Sclerosis/Tuberous Sclerosis Complex (TSC), Panayiotopoulos syndrome, Benign Occipital Epilepsy, Idiopathic childhood occipital epilepsy of Gastaut (ICOE-G), Benign myoclonic epilepsy in infancy, Myoclonic astatic epilepsy (MAE), Cornelia de Lange Syndrome (CdLS), Convulsive Seizures, TBI Seizures, Focal Seizures, Generalized onset Seizures, Progressive Myoclonic Epilepsy, Reflex Epilepsy, Abdominal Epilepsy, Photosensitive Epilepsy, Refractory Epilepsy, Automatism Epilepsy, Catamenial epilepsy, Epilepsia partialis continua, Febrile infection-related epilepsy syndrome (FIRES), Migralepsy, Musicogenic epilepsy, Nocturnal Frontal Lobe epilepsy, Occipital Lobe epilepsy, Post-traumatic (TBI) epilepsy (PTE), Temporal lobe epilepsy (TLE), Unverricht-Lundborg disease (abbreviated ULD or EPM1), Vertiginous epilepsy; Medicinal herbal extracts for treating disease; Medicinal herbal extracts for treating headaches, neurodegeneration, neurogenesis, epilepsy, childhood epilepsy, paediatric encephalopathies, pain, cancer, managing the effects of chemotherapy, Tourette Syndrome, post-traumatic stress disorder (PTSD), nausea, vomiting, premenstrual syndrome (PMS), neurologic conditions, sleep disorders, cognitive decline, facial pain, spasms, gastrointestinal diseases, rare diseases, Alzheimer's disease, appetite loss, cancer, Crohn's disease, anorexia, bulimia, epilepsy, glaucoma, schizophrenia, multiple sclerosis, muscle spasms, nausea, pain, headaches, wasting syndrome (cachexia), and diseases classified as "orphan" by the US Food and Drug Administration, namely, medical cannabis and marijuana extracts for treating diseases and medical conditions classified as "orphan" by the US food and drug administration, namely, Lennox-Gastaut Syndrome, Dravet Syndrome, CDKL5,15q Duplication Syndrome, KCNQ2 related epileptic encephalopathy, SCN8A related epileptic encephalopathy, Electrical status epilepticus in sleep (ESES), Landau-Kleffner syndrome, Continuous spikes and waves during sleep, Tuberous sclerosis complex, Doose Syndrome, Otahara Syndrome, Rett Syndrome, West Syndrome, SYNGAP related epileptic encephalopathy, Fragile X Syndrome, epilepsy with focal cortical dysplasia type II, KCNT1 related epileptic encephalopathy, SCN2A related epileptic encephalopathy, STXBP1 related epileptic encephalopathy, KAND KIF1A related epileptic encephalopathy, HNRNPH2 related epileptic encephalopathy, Phelan-McDermid Syndrome - SHANK3, Angelman Syndrome, Established Status Epilepticus, Refractory Status Epilepticus, Juvenile Myoclonic Epilepsy/Janz Syndrome, Catamenial epilepsy, Drug resistant mesial temporal lobe epilepsy, Occipital Lobe epilepsy, Jeavons syndrome, Benign Rolandic epilepsy or benign childhood epilepsy with centrotemporal spikes (BCECTS), Epilepsy with myoclonic absences, Childhood absence epilepsy (CAE), Tuberous Sclerosis/Tuberous ; Sclerosis Complex (TSC), Panayiotopoulos syndrome, Benign Occipital Epilepsy, Idiopathic childhood occipital epilepsy of Gastaut (ICOE-G), Benign myoclonic epilepsy in infancy, Myoclonic astatic epilepsy (MAE), Cornelia de Lange Syndrome (CdLS), Convulsive Seizures, TBI Seizures, Focal Seizures, Generalized onset Seizures, Progressive Myoclonic Epilepsy, Reflex Epilepsy, Abdominal Epilepsy, Photosensitive Epilepsy, Refractory Epilepsy, Automatism Epilepsy, Catamenial epilepsy, Epilepsia partialis continua, Febrile infection-related epilepsy syndrome (FIRES), Migralepsy, Musicogenic epilepsy, Nocturnal Frontal Lobe epilepsy, Occipital Lobe epilepsy, Post-traumatic (TBI) epilepsy (PTE), Temporal lobe epilepsy (TLE), Unverricht-Lundborg disease (abbreviated ULD or EPM1), Vertiginous epilepsy; medicinal herbal preparations; medicinal herbal preparations for treating headaches, neurodegeneration, neurogenesis, epilepsy, childhood epilepsy, paediatric encephalopathies, pain, cancer, managing the effects of chemotherapy, Tourette Syndrome, post-traumatic stress disorder (PTSD), nausea, vomiting, premenstrual syndrome (PMS), neurologic conditions, sleep disorders, cognitive decline, facial pain, spasms, gastrointestinal diseases, rare diseases, Alzheimer's disease, appetite loss, cancer, Crohn's disease, anorexia, bulimia, epilepsy, glaucoma, schizophrenia, multiple sclerosis, muscle spasms, nausea, pain, headaches, wasting syndrome (cachexia), and diseases classified as "orphan" by the US Food and Drug Administration, namely marijuana preparations, cannabis dried flowers and concentrates for treating diseases and medical conditions classified as "orphan" by the US food and drug administration, namely, Lennox-Gastaut Syndrome, Dravet Syndrome, CDKL5, 15q Duplication Syndrome, KCNQ2 related epileptic encephalopathy, SCN8A related epileptic encephalopathy, Electrical status epilepticus in sleep (ESES), Landau-Kleffner syndrome, Continuous spikes and waves during sleep, Tuberous sclerosis complex, Doose Syndrome, Otahara Syndrome, Rett Syndrome, West Syndrome, SYNGAP related epileptic encephalopathy, Fragile X Syndrome, epilepsy with focal cortical dysplasia type II, KCNT1 related epileptic encephalopathy, SCN2A related epileptic encephalopathy, STXBP1 related epileptic encephalopathy, KAND KIF1A related epileptic encephalopathy, HNRNPH2 related epileptic encephalopathy, Phelan-McDermid Syndrome - SHANK3, Angelman Syndrome, Established Status Epilepticus, Refractory Status Epilepticus, Juvenile Myoclonic Epilepsy/Janz Syndrome, Catamenial epilepsy, Drug resistant mesial temporal lobe epilepsy, Occipital Lobe epilepsy, Jeavons syndrome, Benign Rolandic epilepsy or benign childhood epilepsy with centrotemporal spikes (BCECTS), Epilepsy with myoclonic absences, Childhood absence epilepsy (CAE), ; Tuberous Sclerosis/Tuberous Sclerosis Complex (TSC), Panayiotopoulos syndrome, Benign Occipital Epilepsy, Idiopathic childhood occipital epilepsy of Gastaut (ICOE-G), Benign myoclonic epilepsy in infancy, Myoclonic astatic epilepsy (MAE), Cornelia de Lange Syndrome (CdLS), Convulsive Seizures, TBI Seizures, Focal Seizures, Generalized onset Seizures, Progressive Myoclonic Epilepsy, Reflex Epilepsy, Abdominal Epilepsy, Photosensitive Epilepsy, Refractory Epilepsy, Automatism Epilepsy, Catamenial epilepsy, Epilepsia partialis continua, Febrile infection-related epilepsy syndrome (FIRES), Migralepsy, Musicogenic epilepsy, Nocturnal Frontal Lobe epilepsy, Occipital Lobe epilepsy, Post-traumatic (TBI) epilepsy (PTE), Temporal lobe epilepsy (TLE), Unverricht-Lundborg disease (abbreviated ULD or EPM1), Vertiginous epilepsy; Marijuana derivatives, natural cannabinoids, and synthetic cannabinoids used for treating medical conditions; Marijuana derivatives, natural cannabinoids, and synthetic cannabinoids used for treating headaches, neurodegeneration, neurogenesis, epilepsy, childhood epilepsy, paediatric encephalopathies, pain, cancer, managing the effects of chemotherapy, Tourette Syndrome, post-traumatic stress disorder (PTSD), nausea, vomiting, premenstrual syndrome (PMS), neurologic conditions, sleep disorders, cognitive decline, facial pain, spasms, gastrointestinal diseases, rare diseases, Alzheimer's disease, appetite loss, cancer, managing the effects of chemotherapy, Crohn's disease, anorexia, bulimia, epilepsy, glaucoma, schizophrenia, multiple sclerosis, muscle spasms, nausea, pain, headaches, wasting syndrome (cachexia), and diseases classified as "orphan" by the US Food and Drug Administration, namely liquids, oils, oral sprays, pills, capsules, creams, tinctures, lotions, suppositories, and baked medicinal goods for treating diseases and medical conditions classified as "orphan" by the US food and drug administration, namely, Lennox-Gastaut Syndrome, Dravet Syndrome, CDKL5,15q Duplication Syndrome, KCNQ2 related epileptic encephalopathy, SCN8A related epileptic encephalopathy, Electrical status epilepticus in sleep (ESES), Landau-Kleffner syndrome, Continuous spikes and waves during sleep, Tuberous sclerosis complex, Doose Syndrome, Otahara Syndrome, Rett Syndrome, West Syndrome, SYNGAP related epileptic encephalopathy, Fragile X Syndrome, epilepsy with focal cortical dysplasia type II, KCNT1 related epileptic encephalopathy, SCN2A related epileptic encephalopathy, STXBP1 related epileptic encephalopathy, KAND KIF1A related epileptic encephalopathy, HNRNPH2 related epileptic encephalopathy, Phelan-McDermid Syndrome - SHANK3, Angelman Syndrome, Established Status Epilepticus, Refractory Status Epilepticus, Juvenile Myoclonic Epilepsy/Janz Syndrome, Catamenial epilepsy, Drug resistant mesial temporal lobe epilepsy, Occipital Lobe epilepsy, Jeavons syndrome, Benign Rolandic epilepsy ; or benign childhood epilepsy with centrotemporal spikes (BCECTS), Epilepsy with myoclonic absences, Childhood absence epilepsy (CAE), Tuberous Sclerosis/Tuberous Sclerosis Complex (TSC), Panayiotopoulos syndrome, Benign Occipital Epilepsy, Idiopathic childhood occipital epilepsy of Gastaut (ICOE-G), Benign myoclonic epilepsy in infancy, Myoclonic astatic epilepsy (MAE), Cornelia de Lange Syndrome (CdLS), Convulsive Seizures, TBI Seizures, Focal Seizures, Generalized onset Seizures, Progressive Myoclonic Epilepsy, Reflex Epilepsy, Abdominal Epilepsy, Photosensitive Epilepsy, Refractory Epilepsy, Automatism Epilepsy, Catamenial epilepsy, Epilepsia partialis continua, Febrile infection-related epilepsy syndrome (FIRES), Migralepsy, Musicogenic epilepsy, Nocturnal Frontal Lobe epilepsy, Occipital Lobe epilepsy, Post-traumatic (TBI) epilepsy (PTE), Temporal lobe epilepsy (TLE), Unverricht-Lundborg disease (abbreviated ULD or EPM1), Vertiginous epilepsy; medicinal herbs for treating headaches, neurodegeneration, neurogenesis, epilepsy, childhood epilepsy, paediatric encephalopathies, pain, cancer, managing the effects of chemotherapy, Tourette Syndrome, post-traumatic stress disorder (PTSD), nausea, vomiting, premenstrual syndrome (PMS), neurologic conditions, sleep disorders, cognitive decline, facial pain, spasms, gastrointestinal diseases, rare diseases, Alzheimer's disease, appetite loss, cancer, Crohn's disease, anorexia, bulimia, epilepsy, glaucoma, schizophrenia, multiple sclerosis, muscle spasms, nausea, pain, headaches, wasting syndrome (cachexia), and diseases classified as "orphan" by the US Food and Drug Administration, namely Lennox-Gastaut Syndrome, Dravet Syndrome, CDKL5,15q Duplication Syndrome, KCNQ2 related epileptic encephalopathy, SCN8A related epileptic encephalopathy, Electrical status epilepticus in sleep (ESES), Landau-Kleffner syndrome, Continuous spikes and waves during sleep, Tuberous sclerosis complex, Doose Syndrome, Otahara Syndrome, Rett Syndrome, West Syndrome, SYNGAP related epileptic encephalopathy, Fragile X Syndrome, epilepsy with focal cortical dysplasia type II, KCNT1 related epileptic encephalopathy, SCN2A related epileptic encephalopathy, STXBP1 related epileptic encephalopathy, KAND KIF1A related epileptic encephalopathy, HNRNPH2 related epileptic encephalopathy, Phelan-McDermid Syndrome - SHANK3, Angelman Syndrome, Established Status Epilepticus, Refractory Status Epilepticus, Juvenile Myoclonic Epilepsy/Janz Syndrome, Catamenial epilepsy, Drug resistant mesial temporal lobe epilepsy, Occipital Lobe epilepsy, Jeavons syndrome, Benign Rolandic epilepsy or benign childhood epilepsy with centrotemporal spikes (BCECTS), Epilepsy with myoclonic absences, Childhood absence epilepsy (CAE), Tuberous Sclerosis/Tuberous Sclerosis Complex (TSC), Panayiotopoulos syndrome, Benign Occipital Epilepsy, Idiopathic childhood occipital epilepsy of Gastaut (ICOE-G), Benign myoclonic epilepsy in; infancy, Myoclonic astatic epilepsy (MAE), Cornelia de Lange Syndrome (CdLS), Convulsive Seizures, TBI Seizures, Focal Seizures, Generalized onset Seizures, Progressive Myoclonic Epilepsy, Reflex Epilepsy, Abdominal Epilepsy, Photosensitive Epilepsy, Refractory Epilepsy, Automatism Epilepsy, Catamenial epilepsy, Epilepsia partialis continua, Febrile infection-related epilepsy syndrome (FIRES), Migralepsy, Musicogenic epilepsy, Nocturnal Frontal Lobe epilepsy, Occipital Lobe epilepsy, Post-traumatic (TBI) epilepsy (PTE), Temporal lobe epilepsy (TLE), Unverricht-Lundborg disease (abbreviated ULD or EPM1), Vertiginous epilepsy; medicinal herbs in dried or preserved form for treating headaches, neurodegeneration, neurogenesis, epilepsy, childhood epilepsy, paediatric encephalopathies, pain, cancer, managing the effects of chemotherapy, Tourette Syndrome, post-traumatic stress disorder (PTSD), nausea, vomiting, premenstrual syndrome (PMS), neurologic conditions, sleep disorders, cognitive decline, facial pain, spasms, gastrointestinal diseases, rare diseases, Alzheimer's disease, appetite loss, cancer, Crohn's disease, anorexia, bulimia, epilepsy, glaucoma, schizophrenia, multiple sclerosis, muscle spasms, nausea, pain, headaches, wasting syndrome (cachexia), and diseases classified as "orphan" by the US Food and Drug Administration, namely medical marijuana and cannabis for treating diseases and medical conditions classified as "orphan" by the US food and drug administration, namely, Lennox-Gastaut Syndrome, Dravet Syndrome, CDKL5,15q Duplication Syndrome, KCNQ2 related epileptic encephalopathy, SCN8A related epileptic encephalopathy, Electrical status epilepticus in sleep (ESES), Landau-Kleffner syndrome, Continuous spikes and waves during sleep, Tuberous sclerosis complex, Doose Syndrome, Otahara Syndrome, Rett Syndrome, West Syndrome, SYNGAP related epileptic encephalopathy, Fragile X Syndrome, epilepsy with focal cortical dysplasia type II, KCNT1 related epileptic encephalopathy, SCN2A related epileptic encephalopathy, STXBP1 related epileptic encephalopathy, KAND KIF1A related epileptic encephalopathy, HNRNPH2 related epileptic encephalopathy, Phelan-McDermid Syndrome - SHANK3, Angelman Syndrome, Established Status Epilepticus, Refractory Status Epilepticus, Juvenile Myoclonic Epilepsy/Janz Syndrome, Catamenial epilepsy, Drug resistant mesial temporal lobe epilepsy, Occipital Lobe epilepsy, Jeavons syndrome, Benign Rolandic epilepsy or benign childhood epilepsy with centrotemporal spikes (BCECTS), Epilepsy with myoclonic absences, Childhood absence epilepsy (CAE), Tuberous Sclerosis/Tu; berous Sclerosis Complex (TSC), Panayiotopoulos syndrome, Benign Occipital Epilepsy, Idiopathic childhood occipital epilepsy of Gastaut (ICOE-G), Benign myoclonic epilepsy in infancy, Myoclonic astatic epilepsy (MAE), Cornelia de Lange Syndrome (CdLS), Convulsive Seizures, TBI Seizures, Focal Seizures, Generalized onset Seizures, Progressive Myoclonic Epilepsy, Reflex Epilepsy, Abdominal Epilepsy, Photosensitive Epilepsy, Refractory Epilepsy, Automatism Epilepsy, Catamenial epilepsy, Epilepsia partialis continua, Febrile infection-related epilepsy syndrome (FIRES), Migralepsy, Musicogenic epilepsy, Nocturnal Frontal Lobe epilepsy, Occipital Lobe epilepsy, Post-traumatic (TBI) epilepsy (PTE), Temporal lobe epilepsy (TLE), Unverricht-Lundborg disease (abbreviated ULD or EPM1), Vertiginous epilepsy; pills, capsules, infused with cannabis, medical marijuana, natural cannabinoids, or synthetic cannabinoids; extracts and derivatives of cannabis, medical marijuana, natural cannabinoids, and synthetic cannabinoids for treating headaches, neurodegeneration, neurogenesis, epilepsy, childhood epilepsy, paediatric encephalopathies, pain, cancer, managing the effects of chemotherapy, Tourette Syndrome, post-traumatic stress disorder (PTSD), nausea, vomiting, premenstrual syndrome (PMS), neurologic conditions, sleep disorders, cognitive decline, facial pain, spasms, gastrointestinal diseases, rare diseases, Alzheimer's disease, appetite loss, cancer, Crohn's disease, anorexia, bulimia, epilepsy, glaucoma, schizophrenia, multiple sclerosis, muscle spasms, nausea, pain, headaches, wasting syndrome (cachexia), and diseases classified as "orphan" by the US Food and Drug Administration, namely, salves, concentrates, pastes, extracts, tinctures, marijuana clones, cannabis clones, tissue cultures, powders, juice, resins, oils, and tetrahydrocannabinol (THC) for treating diseases and medical conditions classified as "orphan" by the US food and drug administration, namely, Lennox-Gastaut Syndrome, Dravet Syndrome, CDKL5,15q Duplication Syndrome, KCNQ2 related epileptic encephalopathy, SCN8A related epileptic encephalopathy, Electrical status epilepticus in sleep (ESES), Landau-Kleffner syndrome, Continuous spikes and waves during sleep, Tuberous sclerosis complex, Doose Syndrome, Otahara Syndrome, Rett Syndrome, West Syndrome, SYNGAP related epileptic encephalopathy, Fragile X Syndrome, epilepsy with focal cortical dysplasia type II, KCNT1 related epileptic encephalopathy, SCN2A related epileptic encephalopathy, STXBP1 related epileptic encephalopathy, KAND KIF1A related epileptic encephalopathy, HNRNPH2 related epileptic encephalopathy, Phelan-McDermid Syndrome - SHANK3, Angelman Syndrome, Established Status Epilepticus, Refractory Status Epilepticus, Juvenile Myoclonic Epilepsy/Janz Syndrome, Catamenial epilepsy, Drug resistant mesial temporal lobe epilepsy, Occipital Lobe epilepsy, J; eavons syndrome, Benign Rolandic epilepsy or benign childhood epilepsy with centrotemporal spikes (BCECTS), Epilepsy with myoclonic absences, Childhood absence epilepsy (CAE), Tuberous Sclerosis/Tuberous Sclerosis Complex (TSC), Panayiotopoulos syndrome, Benign Occipital Epilepsy, Idiopathic childhood occipital epilepsy of Gastaut (ICOE-G), Benign myoclonic epilepsy in infancy, Myoclonic astatic epilepsy (MAE), Cornelia de Lange Syndrome (CdLS), Convulsive Seizures, TBI Seizures, Focal Seizures, Generalized onset Seizures, Progressive Myoclonic Epilepsy, Reflex Epilepsy, Abdominal Epilepsy, Photosensitive Epilepsy, Refractory Epilepsy, Automatism Epilepsy, Catamenial epilepsy, Epilepsia partialis continua, Febrile infection-related epilepsy syndrome (FIRES), Migralepsy, Musicogenic epilepsy, Nocturnal Frontal Lobe epilepsy, Occipital Lobe epilepsy, Post-traumatic (TBI) epilepsy (PTE), Temporal lobe epilepsy (TLE), Unverricht-Lundborg disease (abbreviated ULD or EPM1), Vertiginous epilepsy; suppositories infused with cannabis, medical marijuana, natural cannabinoids, cannabis derivatives, or synthetic cannabinoids; Suppositories infused with cannabis, medical marijuana, cannabis derivatives, natural cannabinoids, or synthetic cannabinoids for treating headaches, neurodegeneration, neurogenesis, epilepsy, childhood epilepsy, paediatric encephalopathies, pain, cancer, managing the effects of chemotherapy, Tourette Syndrome, post-traumatic stress disorder (PTSD), nausea, vomiting, premenstrual syndrome (PMS), neurologic conditions, sleep disorders, cognitive decline, facial pain, spasms, gastrointestinal diseases, rare diseases, Alzheimer's disease, appetite loss, cancer, Crohn's disease, anorexia, bulimia, epilepsy, glaucoma, schizophrenia, multiple sclerosis, muscle spasms, nausea, pain, headaches, wasting syndrome (cachexia), and diseases classified as "orphan" by the US Food and Drug Administration, namely, Lennox-Gastaut Syndrome, Dravet Syndrome, CDKL5,15q Duplication Syndrome, KCNQ2 related epileptic encephalopathy, SCN8A related epileptic encephalopathy, Electrical status epilepticus in sleep (ESES), Landau-Kleffner syndrome, Continuous spikes and waves during sleep, Tuberous sclerosis complex, Doose Syndrome, Otahara Syndrome, Rett Syndrome, West Syndrome, SYNGAP related epileptic encephalopathy, Fragile X Syndrome, epilepsy with focal cortical dysplasia type II, KCNT1 related epileptic encephalopathy, SCN2A related epileptic encephalopathy, STXBP1 related epileptic encephalopathy, KAND KIF1A related epileptic encephalopathy, HNRNPH2 related epileptic encephalopathy, Phelan-McDermid Syndrome - SHANK3, Angelman Syndrome, Established Status Epilepticus, Refractory Status Epilepticus, Juvenile Myoclonic Epilepsy/Janz Syndrome, Catamenial epilepsy, Drug resistant mesial temporal lobe epilepsy, Occipital Lobe epilepsy, Jeavons syndrome, Benign Rolandic epilepsy or benign childhood epilepsy with centrotemporal spikes (BCECTS), Epilepsy with myoclonic absences, Childhood absence epilepsy (CAE), Tuberous Sclerosis/Tuberous Sclerosis Complex (TSC), Panayiotopoulos syndrome, Benig; n Occipital Epilepsy, Idiopathic childhood occipital epilepsy of Gastaut (ICOE-G), Benign myoclonic epilepsy in infancy, Myoclonic astatic epilepsy (MAE), Cornelia de Lange Syndrome (CdLS), Convulsive Seizures, TBI Seizures, Focal Seizures, Generalized onset Seizures, Progressive Myoclonic Epilepsy, Reflex Epilepsy, Abdominal Epilepsy, Photosensitive Epilepsy, Refractory Epilepsy, Automatism Epilepsy, Catamenial epilepsy, Epilepsia partialis continua, Febrile infection-related epilepsy syndrome (FIRES), Migralepsy, Musicogenic epilepsy, Nocturnal Frontal Lobe epilepsy, Occipital Lobe epilepsy, Post-traumatic (TBI) epilepsy (PTE), Temporal lobe epilepsy (TLE), Unverricht-Lundborg disease (abbreviated ULD or EPM1), Vertiginous epilepsy; transdermal patches infused with cannabis, medical marijuana, marijuana plant derivatives, natural cannabinoids, or synthetic cannabinoids; Transdermal patches infused with cannabis, medical marijuana, marijuana plant derivatives, natural cannabinoids, or synthetic cannabinoids for treating headaches, neurodegeneration, neurogenesis, epilepsy, childhood epilepsy, paediatric encephalopathies, pain, cancer, managing the effects of chemotherapy, Tourette Syndrome, post-traumatic stress disorder (PTSD), nausea, vomiting, premenstrual syndrome (PMS), neurologic conditions, sleep disorders, cognitive decline, facial pain, spasms, gastrointestinal diseases, rare diseases, Alzheimer's disease, appetite loss, cancer, Crohn's disease, anorexia, bulimia, epilepsy, glaucoma, schizophrenia, multiple sclerosis, muscle spasms, nausea, pain, headaches, wasting syndrome (cachexia), and diseases classified as "orphan" by the US Food and Drug Administration, namely, Lennox-Gastaut Syndrome, Dravet Syndrome, CDKL5,15q Duplication Syndrome, KCNQ2 related epileptic encephalopathy, SCN8A related epileptic encephalopathy, Electrical status epilepticus in sleep (ESES), Landau-Kleffner syndrome, Continuous spikes and waves during sleep, Tuberous sclerosis complex, Doose Syndrome, Otahara Syndrome, Rett Syndrome, West Syndrome, SYNGAP related epileptic encephalopathy, Fragile X Syndrome, epilepsy with focal cortical dysplasia type II, KCNT1 related epileptic encephalopathy, SCN2A related epileptic encephalopathy, STXBP1 related epileptic encephalopathy, KAND KIF1A related epileptic encephalopathy, HNRNPH2 related epileptic encephalopathy, Phelan-McDermid Syndrome - SHANK3, Angelman Syndrome, Established Status Epilepticus, Refractory Status Epilepticus, Juvenile Myoclonic Epilepsy/Janz Syndrome, Catamenial epilepsy, Drug resistant mesial temporal lobe epilepsy, Occipital Lobe epilepsy, Jeavons syndrome, Benign Rolandic epilepsy or benign childhood epilepsy with centrotemporal spikes (BCECTS), Epilepsy with myoclonic absences, Childhood absence epilepsy (CAE), Tuberous Sclerosis/Tuberous Sclerosis Complex (TSC), Panayiotopoulos sy; ndrome, Benign Occipital Epilepsy, Idiopathic childhood occipital epilepsy of Gastaut (ICOE-G), Benign myoclonic epilepsy in infancy, Myoclonic astatic epilepsy (MAE), Cornelia de Lange Syndrome (CdLS), Convulsive Seizures, TBI Seizures, Focal Seizures, Generalized onset Seizures, Progressive Myoclonic Epilepsy, Reflex Epilepsy, Abdominal Epilepsy, Photosensitive Epilepsy, Refractory Epilepsy, Automatism Epilepsy, Catamenial epilepsy, Epilepsia partialis continua, Febrile infection-related epilepsy syndrome (FIRES), Migralepsy, Musicogenic epilepsy, Nocturnal Frontal Lobe epilepsy, Occipital Lobe epilepsy, Post-traumatic (TBI) epilepsy (PTE), Temporal lobe epilepsy (TLE), Unverricht-Lundborg disease (abbreviated ULD or EPM1), Vertiginous epilepsy; Cannabis, cannabinoids, and medical marijuana based petfoods and medications; Cannabis, cannabinoids, and medical marijuana based pet foods and medications for treating pets for veterinary conditions; edible oils and edible butters containing cannabis, medical marijuana, marijuana plant derivatives, natural cannabinoids, or synthetic cannabinoids; Edible oils and edible butters containing cannabis, medical marijuana plant derivatives, natural cannabinoids, or synthetic cannabinoids for treating headaches, neurodegeneration, neurogenesis, epilepsy, childhood epilepsy, paediatric encephalopathies, pain, cancer, managing the effects of chemotherapy, Tourette Syndrome, post-traumatic stress disorder (PTSD), nausea, vomiting, premenstrual syndrome (PMS), neurologic conditions, sleep disorders, cognitive decline, facial pain, spasms, gastrointestinal diseases, rare diseases, Alzheimer's disease, appetite loss, cancer, Crohn's disease, anorexia, bulimia, epilepsy, glaucoma, schizophrenia, multiple sclerosis, muscle spasms, nausea, pain, headaches, wasting syndrome (cachexia), and diseases classified as "orphan" by the US Food and Drug Administration, namely, Lennox-Gastaut Syndrome, Dravet Syndrome, CDKL5,15q Duplication Syndrome, KCNQ2 related epileptic encephalopathy, SCN8A related epileptic encephalopathy, Electrical status epilepticus in sleep (ESES), Landau-Kleffner syndrome, Continuous spikes and waves during sleep, Tuberous sclerosis complex, Doose Syndrome, Otahara Syndrome, Rett Syndrome, West Syndrome, SYNGAP related epileptic encephalopathy, Fragile X Syndrome, epilepsy with focal cortical dysplasia type II, KCNT1 related epileptic encephalopathy, SCN2A related epileptic encephalopathy, STXBP1 related epileptic encephalopathy, KAND KIF1A related epileptic encephalopathy, HNRNPH2 related epileptic encephalopathy, Phelan-McDermid Syndrome - SHANK3, Angelman Syndrome, Established Status Epilepticus, Refractory Status Epilepticus, Juvenile Myoclonic Epilepsy/Janz Syndrome, Catamenial epilepsy, Drug resistant mesial temporal lobe epilepsy, Occipital Lobe epilepsy, Jeavons syndrome, Benign Rolandic epilepsy or benign childhood epilepsy with centrotemporal spikes (BCECTS), Epilepsy with myoclonic absences, Childhood absence epilepsy (CAE), Tuberous Sclerosis/Tuberous Sclerosis Complex (TSC), Panayiotopoulos synd; rome, Benign Occipital Epilepsy, Idiopathic childhood occipital epilepsy of Gastaut (ICOE-G), Benign myoclonic epilepsy in infancy, Myoclonic astatic epilepsy (MAE), Cornelia de Lange Syndrome (CdLS), Convulsive Seizures, TBI Seizures, Focal Seizures, Generalized onset Seizures, Progressive Myoclonic Epilepsy, Reflex Epilepsy, Abdominal Epilepsy, Photosensitive Epilepsy, Refractory Epilepsy, Automatism Epilepsy, Catamenial epilepsy, Epilepsia partialis continua, Febrile infection-related epilepsy syndrome (FIRES), Migralepsy, Musicogenic epilepsy, Nocturnal Frontal Lobe epilepsy, Occipital Lobe epilepsy, Post-traumatic (TBI) epilepsy (PTE), Temporal lobe epilepsy (TLE), Unverricht-Lundborg disease (abbreviated ULD or EPM1), Vertiginous epilepsy; Cannabis, medical marijuana, marijuana plant derivatives, natural cannabinoids, or synthetic cannabinoids - infused foods for medical purposes, namely, frozen foods, treats, desserts, baked goods, desserts, grain based bars, cakes, cereal bars, cookies, brownies, muffins, cupcakes, chocolate, chocolate confectionery, sugar confectionery, candies, gum, jellies, biscuits, ice cream, sorbet, and frozen bars; beverages infused with medical cannabis, medical marijuana, medical marijuana plant derivatives, medical natural cannabinoids, or medical synthetic cannabinoids.

Providing commercial information to the public in the field of medical cannabis and its use in the treatment of medical conditions.